Clinical trial
Topiramate for the Treatment of Methamphetamine Dependence - 1
NCT00345371 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00345371 |
|---|---|
| Title | Topiramate for the Treatment of Methamphetamine Dependence - 1 |
| Official title | Phase 2, Double-Blind, Placebo-Controlled Trial of Topiramate for the Treatment of Methamphetamine Dependence |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Methamphetamine |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo Oral Tablet |
| Enrollment | 140 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 28, 2006 |
| Last update posted | Mar 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: